Europe opens its market to a new generation of GM crops

The adoption of the regulation on new genomic techniques (NGTs) could become the biggest change in EU agricultural biotechnology in decades. Supporters call it a breakthrough for plant breeding and food security, while critics warn of risks for organic production and the increasing influence of multinational seed corporations, writes the French publication Le Monde.

The Gist Briefly

·        The European Parliament has approved a new regulatory framework for plants created using genome editing (NGTs).

·        Some of these crops will be treated as equivalent to those from conventional breeding and can be brought to market through a simplified procedure.

·        Developers promise varieties that are more resistant to drought, disease, and climate stress.

·        The decision could impact the global market for seeds, agrochemicals, and organic products.

What Changed in European Rules

The new regulation introduces a division of plants obtained through genome editing into two categories. The first category includes crops whose genetic changes could have occurred naturally or through classical breeding. These will have a significantly simpler procedure for market approval. The second category will retain stricter controls.

In effect, the EU is moving away from its previous approach, where all crops obtained through new genome editing methods were regulated in the same way as traditional GMOs. European authorities aim to accelerate the creation of varieties resistant to drought, pests, and extreme temperatures.

According to estimates by reform supporters, the new technologies will help reduce the need for pesticides and increase agriculture's resilience to climate change.

Why the Decision Sparked Debate

The main disagreements are not so much about the technology itself, but about patent issues and control over the seed market.

Opponents of the reform fear that simplified market access will allow large biotech companies to expand their patent portfolios and tighten control over plant breeding. During the discussions, the issue of farmer and small seed company dependence on the owners of genetic technologies was actively raised.

Another contentious point concerns organic agriculture. The new genomic crops cannot be used in organic production, and representatives of the organic sector fear potential mixing of seed material and a decline in consumer trust in organic products.

What Consequences This Could Have for Kazakhstan

For Kazakhstan, the EU decision is interesting from several perspectives.

Firstly, the country remains a major importer of seeds for a number of agricultural crops. If European companies begin actively bringing new genome-edited varieties to market, these could become the next generation of imported planting material. This concerns vegetable crops, corn, rapeseed, sugar beet, and several other areas where dependence on foreign breeding remains high.

Secondly, the new varieties could be more resistant to drought and disease. For Kazakhstan, which regularly faces crop losses due to weather anomalies, this looks like a potential advantage. However, it could simultaneously increase dependence on foreign seed suppliers and associated cultivation technologies.

Thirdly, new genomic crops could change the market for plant protection products. If the characteristics claimed by developers are confirmed in practice, the need for certain types of fungicides and insecticides could decrease. However, some of the new varieties will be distributed as part of integrated technology packages, including seeds, digital services, and agrochemical solutions. This implies further market concentration around major international players.

Opportunity for Organic Product Exports

Paradoxically, the EU decision could open up additional opportunities for Kazakhstani organic producers.

Despite the liberalization of rules for NGT crops, Europe's organic sector maintains a ban on their use. This means demand for products with certified organic origin will remain high. Moreover, some consumers may even more actively seek products guaranteed not to be associated with genome editing.

For Kazakhstan, this is a chance to strengthen its position in niche markets for organic grains, oilseeds, and deep-processed products. However, this will require developing its own system of certification, traceability, and origin control.

A Question for Kazakh Science

Another important aspect relates to scientific research. While Europe is effectively opening its market to the results of genome editing, Kazakhstan remains predominantly a consumer of foreign breeding developments.

If the trend towards using NGT crops becomes global, domestic scientific institutes will either have to master similar technologies or strengthen classical breeding to avoid being in the position of a permanent importer of genetic solutions.

Author's Conclusion

The European Parliament's decision could become one of the most significant events for the global agricultural sector in 2026. Europe is effectively acknowledging that new genome editing methods are becoming part of modern plant breeding. For Kazakhstan, this is both an opportunity and a challenge. On one hand, farmers may gain access to more productive and resilient varieties. On the other hand, the risk of technological dependence on foreign seed suppliers and intellectual property increases. Against this backdrop, developing its own breeding science and export niches related to organic production becomes particularly valuable.

#CropProduction #PlantBreeding #SeedProduction #GMO #GenomeEditing #OrganicFarming #Export #AgTech #FoodSecurity #Science